📈 Fed's first cut since 2020: Time to buy the dip? See Tech-focused stock picksUnlock AI Picks

Mankind Pharma Ltd (MNKI)

BSE
Currency in INR
Disclaimer
2,456.35
-42.40(-1.70%)
Closed
MNKI Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Fair Value
Day's Range
2,430.002,516.45
52 wk Range
1,685.002,563.95
Bid/Ask
2,456.35 / 2,465.00
Prev. Close
2,456.35
Open
2,499.8
Day's Range
2,430-2,516.45
52 wk Range
1,685-2,563.95
Volume
10,787
Average Vol. (3m)
21,357
1-Year Change
39.19%
Fair Value
Unlock
Fair Value Upside
Unlock
MNKI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
2,317.38
Downside
-5.66%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Mankind Pharma Ltd Company Profile

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.

Employees
18468
Market
India

Compare MNKI to Peers and Sector

Metrics to compare
MNKI
Peers
Sector
Relationship
P/E Ratio
50.5x43.2x−0.6x
PEG Ratio
1.530.820.00
Price / Book
10.6x6.6x2.6x
Price / LTM Sales
9.3x5.3x3.1x
Upside (Analyst Target)
−5.4%−1.8%56.8%
Fair Value Upside
Unlock−15.8%7.7%Unlock

People Also Watch

1,259.60
METB
-0.34%
2,024.50
JBMA
-1.10%
2,531.00
SAFA
-0.95%
656.20
IONX
-3.29%
1,275.65
MACE
+3.53%

FAQ

What Is the Mankind Pharma (MNKI) Stock Price Today?

The Mankind Pharma stock price today is 2,456.35

What Stock Exchange Does Mankind Pharma Trade On?

Mankind Pharma is listed and trades on the BSE stock exchange.

What Is the Stock Symbol for Mankind Pharma?

The stock symbol for Mankind Pharma is "MNKI."

What Is the Mankind Pharma Market Cap?

As of today, Mankind Pharma market cap is 984.08B.

What is Mankind Pharma Earnings Per Share?

The Mankind Pharma EPS is 48.99.

What Is the Next Mankind Pharma Earnings Date?

Mankind Pharma will release its next earnings report on Oct 29, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.